R&D Systems™ Recombinant Cynomolgus Siglec-9 Fc Chimera Protein

Description

Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is 40.0-480 ng/mL.

Specifications

• Accession Number: XP_005590140.2
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 27180
• Molecular Weight (g/mol): M.W.-observed: 81-91 kDa, under reducing conditions., M.W.-theroretical: 63 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived cynomolgus monkey Siglec-9 protein Cynomolgus Siglec-9 Gln20-Gly350 (Trp165Arg, Glu316Asp) (C-terminus) Accession # XP_005590140.2 IEGRMD Human IgG1 (Pro100-Lys330) (N-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: CD329, CDw329, FOAP-9, OBBP-Like, Protein FOAP-9, sialic acid binding Ig-like lectin 9, sialic acid-binding Ig-like lectin 9, siglec-9, Siglec9
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Siglec-9